Subscriber-only episode

A fun interview with Rachel the Commercial Innovation Manager of ISS/CASIS on her earlier life as a scientist at NASA Ames Research Center, on why working with ISS/CASIS is even more relevant today to all of us, and how it has already had early successes in the commercialization of a few late projects. Rachel also shared with us the challenges we are facing towards scaling such activities and what it is like to attend a party of a rocket launch.  Her full written interview is published here. Rachel will be speaking at 3DHEALS2020 (and answering questions) on microgravity/ISS for 3D printing directly.

Rachel Clemens has focused her career on advancing life science research and product development through experiments in space. In her current role as a Commercial Innovation Manager at the ISS US National Lab, she brings life science research to low earth orbit. She leads partnership development with life science companies – she finds that every sector, from start-ups to big pharma, can benefit from research in space. She is eager to entertain even the craziest of ideas and passionate about finding new solutions to Earth-bound problems. 

After earning a PhD in Molecular Biology from Oregon Health and Science University, Rachel became a Scientist at NASA Ames Research Center leading research on how microgravity affects host-immune systems and microbial pathogenesis. In addition to her current role at the National Lab, Rachel volunteers as a Scientific Project Manager at the Rare Genomics Institute, which connects rare disease patients around the world and provides tools and support to the greater rare disease community. She is based in San Francisco, CA where she blazes trails on foot, conquers hills by bike, and bravely hosts dinner parties in her micro-studio.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

A fun interview with Rachel the Commercial Innovation Manager of ISS/CASIS on her earlier life as a scientist at NASA Ames Research Center, on why working with ISS/CASIS is even more relevant today to all of us, and how it has already had early successes in the commercialization of a few late projects. Rachel also shared with us the challenges we are facing towards scaling such activities and what it is like to attend a party of a rocket launch.  Her full written interview is published here. Rachel will be speaking at 3DHEALS2020 (and answering questions) on microgravity/ISS for 3D printing directly.

Rachel Clemens has focused her career on advancing life science research and product development through experiments in space. In her current role as a Commercial Innovation Manager at the ISS US National Lab, she brings life science research to low earth orbit. She leads partnership development with life science companies – she finds that every sector, from start-ups to big pharma, can benefit from research in space. She is eager to entertain even the craziest of ideas and passionate about finding new solutions to Earth-bound problems. 

After earning a PhD in Molecular Biology from Oregon Health and Science University, Rachel became a Scientist at NASA Ames Research Center leading research on how microgravity affects host-immune systems and microbial pathogenesis. In addition to her current role at the National Lab, Rachel volunteers as a Scientific Project Manager at the Rare Genomics Institute, which connects rare disease patients around the world and provides tools and support to the greater rare disease community. She is based in San Francisco, CA where she blazes trails on foot, conquers hills by bike, and bravely hosts dinner parties in her micro-studio.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

In this follow up interview to Dr. Evin Chen's written interview with us, we learned a lot more about why Taiwan could be an excellent center for healthcare 3D printing and bioprinting innovations.

Dr. YiWen Chen (or Evin Chen) received her M.S. and Ph.D. degrees in Industrial and Manufacturing Engineering (Nanomaterial Group) Florida State University, USA. She joined China Medical University Hospital and funded the 3D Printing Medical Research Center in 2014. She is responsible for leading the team and developing and implementing the 3D printed medical research and clinical application integration. She is also the Associate Professor of Graduate Institute of Biomedical Science at China Medical University since then. Dr. Chen’s research interests focus on developing and delivering advanced and affordable 3D printed medical care including biomedical devices, implants, and therapeutics for medical applications. Several of her patents and technologies have to tech-transfer to industries. She was awarded the 2017 and 2018 Innovation in Taiwan. She is also a member of the Board of Supervisors of the Additive Manufacturing Association in Taiwan(AMAT) and a board of directors of China Medical Derivatives Corporation – Everyoung Biomedical International. She is responsible for providing relevant technical advice and is often invited to serve as lecturers at many international academic conferences. Many achievements of her research team are also recognized by high-impact journals, media, conference scientific publications, and published works. She has published 35 peer-reviewed articles and holds 15 issued/pending patents. Dr. Chen will be a speaker for the upcoming 3DHEALS2020 conference.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

Subscriber-only episode

In this follow up interview to Dr. Evin Chen's written interview with us, we learned a lot more about why Taiwan could be an excellent center for healthcare 3D printing and bioprinting innovations.

Dr. YiWen Chen (or Evin Chen) received her M.S. and Ph.D. degrees in Industrial and Manufacturing Engineering (Nanomaterial Group) Florida State University, USA. She joined China Medical University Hospital and funded the 3D Printing Medical Research Center in 2014. She is responsible for leading the team and developing and implementing the 3D printed medical research and clinical application integration. She is also the Associate Professor of Graduate Institute of Biomedical Science at China Medical University since then. Dr. Chen’s research interests focus on developing and delivering advanced and affordable 3D printed medical care including biomedical devices, implants, and therapeutics for medical applications. Several of her patents and technologies have to tech-transfer to industries. She was awarded the 2017 and 2018 Innovation in Taiwan. She is also a member of the Board of Supervisors of the Additive Manufacturing Association in Taiwan(AMAT) and a board of directors of China Medical Derivatives Corporation – Everyoung Biomedical International. She is responsible for providing relevant technical advice and is often invited to serve as lecturers at many international academic conferences. Many achievements of her research team are also recognized by high-impact journals, media, conference scientific publications, and published works. She has published 35 peer-reviewed articles and holds 15 issued/pending patents. Dr. Chen will be a speaker for the upcoming 3DHEALS2020 conference.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

Join me for a fascinating conversation with 3DHEALS2020 speaker, Kevin Caldwell, CEO and co-founder of Ossium Health, a startup building a bone marrow bank, and providing solutions to more available bone marrow transplant and other related cell therapies. Learn more about Kevin's personal journey as an entrepreneur, how such a bone marrow/stem cell band from organ donors can help biofabrication and tissue engineering, and the bioethical concerns with cell therapy and tissue engineering. The video version of this interview can be found here. Stay tuned for more in-depth written interview with Kevin at 3DHEALS.com.

Guest Biography: 

Kevin E. Caldwell II is the Co-founder, President & CEO of Ossium  Health, where he leads a team that is building the world’s first bone marrow bank. Kevin previously worked in consulting as an Engagement Manager at leading strategy consulting firm 
McKinsey. Prior to that, he served in the Quantitative Research department of the hedge fund Bridgewater Associates. Kevin was trained in Physics and Economics at MIT before receiving his JD from Harvard Law School.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

Join me for a fascinating conversation with 3DHEALS2020 speaker, Kevin Caldwell, CEO and co-founder of Ossium Health, a startup building a bone marrow bank, and providing solutions to more available bone marrow transplant and other related cell...

A fascinating conversation with upcoming 3DHEALS2020 speaker Dr. Stephanie Willerth on where bioprinting and biofabrication technology is to help with drug development and screening of neurological diseases such as Alzheimer's disease if we can create tissue replacements, "mini-brain", as well as her new bio-ink startup, Axolotl Biosciences.

See the full interview here.

Dr. Willerth holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences as an Associate Professor.

She serves as the Acting Director for the Centre for Biomedical Research at the University of Victoria and on the steering committee of the B.C. Regenerative Medicine Initiative. She also served as the President of the Canadian Biomaterials Society from 2017-2018. Her honors include being named the 2018 REACH award winner for Excellence in Undergraduate Research-inspired Teaching, a Woman of Innovation in 2017, one of the 2015 Young Innovators in Cellular and Biological Engineering and a “Star in Global Health” by Grand Challenges Canada in 2014.  She spent Fall of 2016 on sabbatical at the Wisconsin Institute for Discovery supported by the International Collaboration on Repair Discoveries International Travel Award where she wrote her book “Engineering neural tissue using stem cells” published by Academic Press.

She completed her postdoctoral work at the University of California-Berkeley after receiving her Ph.D. in Biomedical Engineering from Washington University. Her undergraduate degrees were in Biology and Chemical Engineering from the Massachusetts Institute of Technology. Dr. Willerth will be speaking at the upcoming virtual 3DHEALS2020.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

Subscriber-only episode

A fascinating conversation with upcoming 3DHEALS2020 speaker Dr. Stephanie Willerth on where bioprinting and biofabrication technology is to help with drug development and screening of neurological diseases such as Alzheimer's disease if we can create tissue replacements, "mini-brain", as well as her new bio-ink startup, Axolotl Biosciences.

See the full interview here.

Dr. Willerth holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences as an Associate Professor.

She serves as the Acting Director for the Centre for Biomedical Research at the University of Victoria and on the steering committee of the B.C. Regenerative Medicine Initiative. She also served as the President of the Canadian Biomaterials Society from 2017-2018. Her honors include being named the 2018 REACH award winner for Excellence in Undergraduate Research-inspired Teaching, a Woman of Innovation in 2017, one of the 2015 Young Innovators in Cellular and Biological Engineering and a “Star in Global Health” by Grand Challenges Canada in 2014.  She spent Fall of 2016 on sabbatical at the Wisconsin Institute for Discovery supported by the International Collaboration on Repair Discoveries International Travel Award where she wrote her book “Engineering neural tissue using stem cells” published by Academic Press.

She completed her postdoctoral work at the University of California-Berkeley after receiving her Ph.D. in Biomedical Engineering from Washington University. Her undergraduate degrees were in Biology and Chemical Engineering from the Massachusetts Institute of Technology. Dr. Willerth will be speaking at the upcoming virtual 3DHEALS2020.

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

In this interview, professor Nick Dechev shared with us the history of Victoria Hand Project,  a nonprofit organization focusing on 3D printed upper limb prosthetics. Nick shared with us the technologies and the people behind it, and how the organization is making an impact in eight developing countries and now moving into underserved communities in the U.S. and Canada with new funding.

Nick Dechev received his Ph.D. in Mechanical Engineering from the University of Toronto, Canada, in 2004, and joined the University of Victoria in 2005.  He is currently an Associate Professor in the Faculty of Engineering and is presently Director of the Biomedical Engineering Program. Dr. Dechev’s research program involves biomedical system design with application areas centered on advanced hand prosthesis and bio-sensor design.  These areas include 3D printing of hand prosthesis, implantable sensor design for the acquisition of bio-signals, and wireless power transfer technology for implantable sensors. These projects aim at developing better methods for the control of advanced hand prosthesis.  He is also the Executive Director of the Victoria Hand Project, a non-profit dedicated to providing hand prostheses to amputees in need in developing countries. Professor Dechev will be a speaker at the #3DHEALS2020 conference focusing on point of care 3D printing with his work with VHP. 

Send us a text

Subscribe to our premium version and support the show.

Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel

About Pitch3D

In this interview, professor Nick Dechev shared with us the history of Victoria Hand Project,  a nonprofit organization focusing on 3D printed upper limb prosthetics. Nick shared with us the technologies and the people behind it, and how the...